Cubicin
103060-53-3
1620.67
C72H101N17O26
DMSO, Ethanol
-20°C
Daptomycin is an antibiotic derived from Streptomyces roseosporus that targets Gram-positive bacteria by binding to and depolarizing their cell membranes, eventually causing cell death through loss of ordinary membrane potential.
Daptomycin is a member of the cyclic lipopeptide class of compounds, a relatively new and novel group of antibiotics. Owing to their unique mechanisms of action, these antibiotics do not display cross-resistance with more traditional antibiotic drugs.
Daptomycin is used principally in clinical medicine for the treatment of Gram-positive skin infections. It has become increasingly relied upon as a treatment for infective endocarditis. Research has also shown it to be a safe and effective treatment for osteomyelitis. Daptomycin has been found to be equally effective as vancomycin against MRSA.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
